Kaiser R, Kern A, Kampa D, Neumann-Haefelin D
Neurologische Klinik und Poliklinik, Albert-Ludwigs-Universität Freiburg.
Zentralbl Bakteriol. 1997 Nov;286(4):534-41. doi: 10.1016/s0934-8840(97)80057-6.
With the intention to evaluate the frequency of asymptomatic infections with TBE virus and B. burgdorferi clinical data and serum specimens were collected from 393 individuals living in an area endemic for both agents (Freiburg, southern Germany). Sera were examined by ELISA. Borderline and positive results were checked by immunoblotting. Only specific antibodies detected by immunoblotting (B. burgdorferi: 22 kDa, 31 kDa, 34 kDa, 39 kDa, 83 kDa; TBE: glycoprotein E) were assessed as positive findings. Specific antibodies to B. burgdorferi were detected in 17/105 individuals with possible symptoms of borreliosis (16%) and in 36/288 individuals without current or previous symptoms of borreliosis (12.5%). Antibody to TBE virus was demonstrated in 34/361 individuals (9.4%) without clinical symptoms of TBE or vaccination against TBE. Thirty individuals had been immunised against TBE (10.6%) and two had clinical TBE one year ago. Antibodies against both agents were detected only in 1.5% of all subjects. Considering the low seroprevalence, antibody screening is not recommended prior to TBE vaccination.
为了评估蜱传脑炎病毒(TBE)和伯氏疏螺旋体无症状感染的频率,我们从生活在这两种病原体的地方性流行区(德国南部弗赖堡)的393个人中收集了临床数据和血清样本。血清通过酶联免疫吸附测定(ELISA)进行检测。临界和阳性结果通过免疫印迹法进行检查。只有通过免疫印迹法检测到的特异性抗体(伯氏疏螺旋体:22 kDa、31 kDa、34 kDa、39 kDa、83 kDa;蜱传脑炎:糖蛋白E)被评估为阳性结果。在105名可能有莱姆病症状的个体中有17名(16%)检测到伯氏疏螺旋体特异性抗体,在288名目前或既往无莱姆病症状的个体中有36名(12.5%)检测到该抗体。在361名无蜱传脑炎临床症状或未接种过蜱传脑炎疫苗的个体中有34名(9.4%)检测到蜱传脑炎病毒抗体。30人曾接种过蜱传脑炎疫苗(10.6%),2人一年前患过临床型蜱传脑炎。仅在所有受试者的1.5%中检测到针对这两种病原体的抗体。考虑到血清阳性率较低,不建议在蜱传脑炎疫苗接种前进行抗体筛查。